Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 14 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 543 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
81 (9%) |
|
Overdue reports |
2 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 600MG 300MG 200MG | TABLET | Resolved | 2018-04-27 | 2019-06-19 | 47356 |
| MYLAN-SUMATRIPTAN | 50MG | TABLET | Resolved | 2018-05-01 | 2018-08-01 | 47809 |
| MYLAN-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2018-05-01 | 2018-07-04 | 47862 |
| MYLAN-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-05-03 | 2018-05-03 | 48193 |
| MYLAN-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-05-03 | 2018-05-03 | 48201 |
| MYLAN-ATENOLOL | 100MG | TABLET | Resolved | 2018-06-04 | 2018-07-05 | 51255 |
| MYLAN-CIPROFLOXACIN | 250MG | TABLET | Resolved | 2018-06-04 | 2018-07-05 | 51272 |
| MYLAN-CIPROFLOXACIN | 500MG | TABLET | Resolved | 2018-06-04 | 2018-07-05 | 51278 |
| MYLAN-CITALOPRAM | 40MG | TABLET | Resolved | 2018-06-04 | 2018-07-05 | 51300 |
| MYLAN-FLUOXETINE | 10MG | CAPSULE | Resolved | 2018-06-05 | 2018-07-05 | 51433 |
| MYLAN-FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-06-05 | 2018-07-05 | 51441 |
| ESME 21 | 20MCG 100MCG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51450 |
| ESME 28 | 20MCG 100MCG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51453 |
| MYLAN-LOSARTAN | 100MG | TABLET | Resolved | 2018-06-05 | 2018-08-11 | 51460 |
| MYLAN-OLANZAPINE | 2.5MG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51475 |
| MYLAN-OLANZAPINE | 5MG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51478 |
| MYLAN-OLANZAPINE | 7.5MG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51481 |
| MYLAN-OLANZAPINE | 10MG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51484 |
| MYLAN-OLANZAPINE | 15MG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51489 |
| MYLAN-PAROXETINE | 10MG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51520 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |